Alvotech Renews Market Making Agreement with Islandsbanki for ALVO Shares on Nasdaq Iceland

Alvotech and Islandsbanki have renewed their market making agreement for ALVO shares trading on Nasdaq Iceland. The renewed agreement aims to enhance the liquidity and efficiency of trading in Alvotech shares on the Icelandic stock exchange.

Under the terms of the agreement, Islandsbanki will act as a market maker for ALVO shares, providing continuous bid and ask quotes during trading hours. This commitment helps to narrow the spread between buying and selling prices, facilitating smoother trading for investors. The renewed agreement signifies a continued partnership between Alvotech, a global biotech company specializing in biosimilar medicines, and Islandsbanki, a leading financial institution in Iceland.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 1, 2026

Author

GOAI